- ICH GCP
- US-Register für klinische Studien
- Klinische Studie NCT05777343
Bewegung, PNE und kognitives Training bei Personen mit chronischen Rückenschmerzen
Schmerzneurowissenschaftliche Aufklärung, Bewegung und kognitives Training bei Personen mit idiopathischen chronischen Rückenschmerzen: eine dreiarmige randomisierte Studie
This study aims of to investigate whether combining cognitive training to exercise and Pain Neuroscience Education will contribute to reduction of pain and associated symptoms (i.e., catastrophizing, fear of movement, disability) in individuals with low back pain (LBP).
Studienübersicht
Status
Bedingungen
Intervention / Behandlung
Detaillierte Beschreibung
This study aims of to investigate whether combining cognitive training to exercise and Pain Neuroscience Education (PNE) will contribute to reduction of pain and associated symptoms (i.e., catastrophizing, fear of movement, disability) in individuals with low back pain (LBP).
It will have three arms of which will receive exercise, PNE and/or cognitive training for 8 weeks (Group I - exercise and PNE; Group II - exercise, PNE and cognitive training; Group III - cognitive training).
Participants will be assessed for pain characteristics, psychological, and cognitive aspects at baseline, post-intervention and at 3 months follow-up.
Studientyp
Einschreibung (Tatsächlich)
Phase
- Unzutreffend
Kontakte und Standorte
Studienorte
-
-
Aveiro District
-
Aveiro, Aveiro District, Portugal
- University of Aveiro
-
-
Teilnahmekriterien
Zulassungskriterien
Studienberechtigtes Alter
Akzeptiert gesunde Freiwillige
Studienberechtigte Geschlechter
Beschreibung
Inclusion Criteria:
- have chronic idiopathic LBP
- report pain intensity of at least 2 out of 10 on the Numeric Pain Rating Scale
- 18 to 64 years old
- Be able to read, write and speak Portuguese
- Asses to personal computer and internet for those receiving cognitive training
Exclusion Criteria:
- individuals receiving any chronic treatment for their pain
- symptoms of peripheral nervous system pathology (e.g., motor weakness and sensory disturbance);
- a diagnosis of an ongoing neurological disease with peripheral or central nervous system involvement or relevant sequela;
- having a diagnosis of ongoing psychiatric disease
- having relevant cognitive impairment as assessed by Montreal Cognitive Assessment (MoCA).
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
- Hauptzweck: Behandlung
- Zuteilung: Zufällig
- Interventionsmodell: Parallele Zuordnung
- Maskierung: Single
Waffen und Interventionen
Teilnehmergruppe / Arm |
Intervention / Behandlung |
|---|---|
|
Experimental: Intervention 1
Participants will receive exercise, PNE and online cognitive training sessions. |
Cognitive training combined with the recommended non-pharmacological intervention (Exercise and Pain Neuroscience Education). |
|
Aktiver Komparator: Intervention 2
Participants will receive exercise and pain neuroscience education (PNE). |
Recommended non-pharmacological intervention (Exercise and Pain Neuroscience Education). |
|
Aktiver Komparator: Intervention 3
Participants will receive online cognitive training sessions. |
Online sessions of cognitive training. |
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Numeric Pain Rating Scale Numeric Pain Rating Scale
Zeitfenster: baseline
|
Measured with a 11-point scale ranging from 0 meaning "no pain" to 10 meaning "the worst pain imaginable". |
baseline
|
|
Numeric Pain Rating Scale Numeric Pain Rating Scale
Zeitfenster: post-intervention - 8 weeks
|
Measured with a 11-point scale ranging from 0 meaning "no pain" to 10 meaning "the worst pain imaginable". |
post-intervention - 8 weeks
|
|
Numeric Pain Rating Scale Numeric Pain Rating Scale
Zeitfenster: 3 months follow-up
|
Measured with a 11-point scale ranging from 0 meaning "no pain" to 10 meaning "the worst pain imaginable". |
3 months follow-up
|
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Cognitive Function
Zeitfenster: baseline
|
Cognitive function will be assessed using the Brain on Track® (BoT), a self-administered computerized test that evaluates different cognitive domains. Each test has a virtually unlimited range score and considers the maximum number of correct answers that a person gives in a fixed period of time and higher scores represent higher cognitive performance. |
baseline
|
|
Cognitive Function
Zeitfenster: post-intervention - 8 weeks
|
Cognitive function will be assessed using the Brain on Track® (BoT), a self-administered computerized test that evaluates different cognitive domains. Each test has a virtually unlimited range score and considers the maximum number of correct answers that a person gives in a fixed period of time and higher scores represent higher cognitive performance. |
post-intervention - 8 weeks
|
|
Cognitive Function
Zeitfenster: 3 months follow-up.
|
Cognitive function will be assessed using the Brain on Track® (BoT), a self-administered computerized test that evaluates different cognitive domains. Each test has a virtually unlimited range score and considers the maximum number of correct answers that a person gives in a fixed period of time and higher scores represent higher cognitive performance. |
3 months follow-up.
|
|
Roland Morris disability questionnaire
Zeitfenster: baseline
|
The Roland Morris assesses disability caused by LBP. It has 24 statements, and the individual must tick those that relate to him that day. The total score ranges from "0" meaning no disability to "24" meaning maximum disability. |
baseline
|
|
Roland Morris disability questionnaire
Zeitfenster: post-intervention - 8 weeks
|
The Roland Morris assesses disability caused by LBP. It has 24 statements, and the individual must tick those that relate to him that day. The total score ranges from "0" meaning no disability to "24" meaning maximum disability. |
post-intervention - 8 weeks
|
|
Roland Morris disability questionnaire
Zeitfenster: 3 months follow-up
|
The Roland Morris assesses disability caused by LBP. It has 24 statements, and the individual must tick those that relate to him that day. The total score ranges from "0" meaning no disability to "24" meaning maximum disability. |
3 months follow-up
|
|
Central sensitization Inventory
Zeitfenster: baseline
|
The central sensitization inventory (CSI) assesses symptoms of central sensitization. The total score ranges from 0 to 100 points and to identify central sensitization in individuals, the recommended cut-off score is 40 points. |
baseline
|
|
Central sensitization Inventory
Zeitfenster: post-intervention - 8 weeks
|
The central sensitization inventory (CSI) assesses symptoms of central sensitization. The total score ranges from 0 to 100 points and to identify central sensitization in individuals, the recommended cut-off score is 40 points. |
post-intervention - 8 weeks
|
|
Central sensitization Inventory
Zeitfenster: 3 months follow-up
|
The central sensitization inventory (CSI)assesses symptoms of central sensitization. The total score ranges from 0 to 100 points and to identify central sensitization in individuals, the recommended cut-off score is 40 points. |
3 months follow-up
|
|
Hospital Anxiety and Depression Scale (HADS)
Zeitfenster: baseline
|
HADS evaluates symptoms of anxiety and depression. The total scores range from 0 to 21 points with a 4-point Likert scale rating between "most of the times" and "not at all" with higher scores indicating higher levels of anxiety and depression. |
baseline
|
|
Hospital Anxiety and Depression Scale (HADS)
Zeitfenster: post-intervention - 8 weeks
|
HADS evaluates symptoms of anxiety and depression. The total scores range from 0 to 21 points with a 4-point Likert scale rating between "most of the times" and "not at all" with higher scores indicating higher levels of anxiety and depression. |
post-intervention - 8 weeks
|
|
Hospital Anxiety and Depression Scale (HADS)
Zeitfenster: 3 months follow-up.
|
HADS evaluates symptoms of anxiety and depression. The total scores range from 0 to 21 points with a 4-point Likert scale rating between "most of the times" and "not at all" with higher scores indicating higher levels of anxiety and depression. |
3 months follow-up.
|
|
TAMPA Scale of Kinesiophobia
Zeitfenster: baseline
|
The Tampa scale measures the fear of movement related to chronic LBP. The short version has 13 items in a 4-point Likert scale rating between "strongly disagree" and "strongly agree". The total scores range from 0 to 52 points with higher levels indicating higher fear of movement. |
baseline
|
|
TAMPA Scale of Kinesiophobia
Zeitfenster: post-intervention - 8 weeks
|
The Tampa scale measures the fear of movement related to chronic LBP. The short version has 13 items in a 4-point Likert scale rating between "strongly disagree" and "strongly agree". The total scores range from 0 to 52 points with higher levels indicating higher fear of movement. |
post-intervention - 8 weeks
|
|
TAMPA Scale of Kinesiophobia
Zeitfenster: 3 months follow-up.
|
The Tampa scale measures the fear of movement related to chronic LBP. The short version has 13 items in a 4-point Likert scale rating between "strongly disagree" and "strongly agree". The total scores range from 0 to 52 points with higher levels indicating higher fear of movement. |
3 months follow-up.
|
|
Pain Catastrophizing Scale
Zeitfenster: Baseline
|
The Pain Catastrophizing Scale (PCS) assess catastrophic thinking related to pain. It has 13 statements on a 5-point scale ranging from 0 meaning "not at all" and 4 meaning "all the time". The total score ranges from 0 to 52 with higher scores indicating higher levels of catastrophizing. |
Baseline
|
|
Pain Catastrophizing Scale
Zeitfenster: post-intervention - 8 weeks
|
The Pain Catastrophizing Scale (PCS) assess catastrophic thinking related to pain. It has 13 statements on a 5-point scale ranging from 0 meaning "not at all" and 4 meaning "all the time". The total score ranges from 0 to 52 with higher scores indicating higher levels of catastrophizing. |
post-intervention - 8 weeks
|
|
Pain Catastrophizing Scale
Zeitfenster: 3 months follow-up.
|
The Pain Catastrophizing Scale (PCS) assess catastrophic thinking related to pain. It has 13 statements on a 5-point scale ranging from 0 meaning "not at all" and 4 meaning "all the time". The total score ranges from 0 to 52 with higher scores indicating higher levels of catastrophizing. |
3 months follow-up.
|
|
Basic Scale on Insomnia Complaints and Quality of Sleep (BaSIQs)
Zeitfenster: baseline
|
The scale assess the difficulties with sleep onset and maintenance and the quality and depth of sleep during the last month and considering a normal week. Total score ranges from 0 to 28 points and higher scores are associated with poor quality of sleep. |
baseline
|
|
Basic Scale on Insomnia Complaints and Quality of Sleep (BaSIQs)
Zeitfenster: post-intervention - 8 weeks
|
The scale assess the difficulties with sleep onset and maintenance and the quality and depth of sleep during the last month and considering a normal week. Total score ranges from 0 to 28 points and higher scores are associated with poor quality of sleep. |
post-intervention - 8 weeks
|
|
Basic Scale on Insomnia Complaints and Quality of Sleep (BaSIQs)
Zeitfenster: 3 months follow-up.
|
The scale assess the difficulties with sleep onset and maintenance and the quality and depth of sleep during the last month and considering a normal week. Total score ranges from 0 to 28 points and higher scores are associated with poor quality of sleep. |
3 months follow-up.
|
|
Two-point discrimination
Zeitfenster: baseline
|
Two-point discrimination is used to assess cortical reorganization. |
baseline
|
|
Two-point discrimination
Zeitfenster: post-intervention - 8 weeks
|
Two-point discrimination is used to assess cortical reorganization. |
post-intervention - 8 weeks
|
|
Two-point discrimination
Zeitfenster: 3 months follow-up
|
Two-point discrimination is used to assess cortical reorganization. |
3 months follow-up
|
|
Patient's Global Impression of Change (PGIC)
Zeitfenster: post-intervention - 8 weeks
|
PGIC evaluates the perception of improvement associated with the intervention. Participants are instructed to select on a scale from 1 ("No change or condition worsened") to 7 ("Much better, and with a considerable improvement that made all the difference") the statement that best reflected the impact of the intervention on their condition. |
post-intervention - 8 weeks
|
|
Patient's Global Impression of Change (PGIC)
Zeitfenster: 3 months follow-up.
|
PGIC evaluates the perception of improvement associated with the intervention. Participants are instructed to select on a scale from 1 ("No change or condition worsened") to 7 ("Much better, and with a considerable improvement that made all the difference") the statement that best reflected the impact of the intervention on their condition. |
3 months follow-up.
|
Mitarbeiter und Ermittler
Sponsor
Ermittler
- Studienleiter: Anabela Silva, PhD, School of Health Sciences, University of Aveiro
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn (Tatsächlich)
Primärer Abschluss (Tatsächlich)
Studienabschluss (Tatsächlich)
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Tatsächlich)
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Schlüsselwörter
Zusätzliche relevante MeSH-Bedingungen
- Verhalten
- Motorik
- Motorik
- Bewegung
- Phänomen des Bewegungsapparates muskuloskelettal
- Muskuloskelettaler und neuronales physiologisches Phänomen
- Therapeutika
- Patientenversorgung
- Gesundheitsdienste
- Belegschaft und Dienstleistungen für Gesundheitseinrichtungen
- Rehabilitation
- Nachbehandlung
- Kontinuität der Patientenversorgung
- Neurologische Rehabilitation
- Übung
- Kognitiver Training
Andere Studien-ID-Nummern
- RCTCognitiveTraining
Plan für individuelle Teilnehmerdaten (IPD)
Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?
Beschreibung des IPD-Plans
Individual participant data are not publicly available due to ethical and privacy restrictions of the approved study protocol. An anonymized analysis dataset may be made available to qualified researchers upon reasonable request to the principal investigator and subject to approval by the Ethics and Deontology Council of the University of Aveiro.
Arzneimittel- und Geräteinformationen, Studienunterlagen
Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt
Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .